Biosimilars Market New Industry Research on Present State & Future Growth and Analysis Prospects to 2028

According to our new research study on "Biosimilars Market Forecast To 2028 - Global Analysis by Disease Indication, Drug Class, Route of Administration, End User," the biosimilars market size is expected to reach US$ 18,435.89 million in 2021 to US$ 1,36,069.53 million by 2028; it is estimated to register a CAGR of 34.8% during the forecast period.

Download Sample Pages of this Research Study at - https://www.theinsightpartners.com/sample/TIPHE100001246/?utm_source=OpenPR&utm_medium=10129

The report highlights trends prevailing in the market, and the factors driving and hindering the biosimilars market growth. The growth of the global biosimilars market is attributed to the increasing prevalence of chronic diseases, the cost-effectiveness of biosimilar drugs, and the rising approvals of biosimilars. Additionally, the collaborations among manufacturers for biosimilars and clinical trials are likely to emerge as significant future trends in the market during the forecast period. However, high-cost involvement and complexities in biosimilar product manufacturing are among the market deterrent factors.

Based on disease indication, the global biosimilars market is segmented into cancer, diabetes, autoimmune disease, and other disease indication. The cancer segment held the largest market share in 2021 and autoimmune disease is anticipated to register the highest CAGR of 36.1% during the forecast period (2022-2028). Biosimilars have been used in many disease areas, including oncology. They are safe and effective while lowering drug costs and increasing access to more patients worldwide. The treatment of cancer continues to place a signi?cant burden on healthcare systems, with the number of cancer cases continuing to rise due to an aging population.

The key players profiled in this study includes: Amgen Inc, Celltrion Inc, Sanofi SA, Biocon Ltd, Pfizer Inc, Samsung Bioepis Co Ltd, Coherus BioSciences Inc, Eli Lilly and Co, Sandoz AG, Teva Pharmaceutical Industries Ltd, and Dr. Reddy's Laboratories Ltd are among the leading companies operating in the global biosimilars market.

Speaking about this research report in particular, it includes:
• Five Types of Segmentations
• Five Major Regions (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
• Market Information For 10 Years (2017 & 2018 - Historic Years, 2019 - Base Year and 2020-2028 Forecast Period)
• Key Industry Dynamics including factors that are Driving the Market, Prevailing Deterrent, Potential Opportunities as Well as Future Trends.
• Ten Company Profiles (these are not just Major Players but a Mix of Leading, Emerging Players, Market Disruptors, Niche Market Players, etc.)
• Industry Landscape Analysis
• Analysis of COVID-19 Impact on this market at Global and Regional Level.

A thoroughgoing evaluation of the market restrains included in the report which represents the difference to drivers of the market and gives scope for strategic insights and developments. The research study has amalgamated the growth analysis of different aspects that enhance the market growth scenario. It constitutes key market drivers, restraints and trends that transform the market in either a positive or negative manner.

According to the CDC (Centers for Disease Control and Prevention), each year in the UK, about 24,500 men and 10,000 women get cancer, and about 18,600 men and 9,000 women die from the disease. The percentage who gets cancer has been rising for several decades. Liver cancer is more common in other parts of the world than in the UK. Moreover, according to an article published in CCO (Chinese Clinical Oncology), hepatocellular cancer (HCC) is a leading cause of cancer death worldwide.

Inquire before Buying Copy of Biosimilars Market: https://www.theinsightpartners.com/inquiry/TIPHE100001246/?utm_source=OpenPR&utm_medium=10129

The impact of COVID-19 on the biosimilar market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current pandemic is expected to delay the process of product approvals and launches, hindering the market's growth. Additionally, as per the research article titled "Impact of Covid-19 on Cancer Care: A Global Collaborative Study" published in September 2020, nearly 88% of the cancer care centers faced challenges in delivering usual cancer care for many reasons, including preventive measures, lack of personal protective equipment, and staff shortages due to COVID-19.

The report segments the biosimilars market as follows:
Based on the disease indication, the biosimilars market is segmented into cancer, diabetes, autoimmune disease, and other disease indication. Based on drug class, the biosimilars market is segmented into granulocyte colony-stimulating factors, human growth hormone, insulin, TNF blockers and monoclonal antibodies, and others (osteoporosis, etc). Based on route of administration, the biosimilars market is segmented into intravenous, subcutaneous, and other applications. Based on geography, the biosimilars market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

The Table of Content for Biosimilars Market research study includes:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. Biosimilars Market Landscape
5. Biosimilars Market - Key Market Dynamics
6. Biosimilars Market - Global Market Analysis
7. Biosimilars Market - Revenue And Forecasts to 2028 - Type
8. Biosimilars Market - Revenue And Forecasts to 2028 - Type of Product
9. Biosimilars Market - Revenue And Forecasts to 2028 - Service
10. Biosimilars Market Revenue And Forecasts to 2028 - Geographical Analysis
11. Impact of Covid-19 Pandemic on Global Biosimilars Market
12. Industry Landscape
13. Biosimilars Market, Key Company Profiles
14. Appendix
15. List of Tables
16. List of Figures

Directly Purchase a Copy of this Research Study at - https://www.theinsightpartners.com/buy/TIPHE100001246/?utm_source=OpenPR&utm_medium=10129

Additionally, in case you are interested in other topic at the moment, please share your exact requirements with us as apart from our off-the-shelf reports, we also provide customized reports that are prepared keeping in view the clients precise requirements. To let you know, on an annual basis, we publish over 450+ report across 18 distinct industry verticals.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.